Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ACTRN12626000081314) titled 'Daridorexant treatment in adults with migraine and insomnia: an exploratory study of sleep and headache outcomes' on Jan. 21.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: Vivek Milan Keshani at Sunnybrook Hopsital, Toronto, Ontario
Condition:
Chronic migraine
Chronic Insomnia
Chronic migraine
Chronic Insomnia
Neurological - Other neurological disorders
Intervention:
Brief name: Daridorexant (International Non-proprietary Name)
Intervention descripti...